EMEA affirms Gardasil after two deaths

Two young women died suddenly and mysteriously after getting the Gardasil vaccine, European regulators announced yesterday. Did the vaccine precipitate their deaths? No one knows. But Europe's drug watchdogs emphasized the fact that 1.5 million women have been vaccinated with Gardasil so far, and they said the benefits of this cervical cancer preventative still outweigh the risks.

Sanofi Pasteur, which collaborated with Merck in developing Gardasil and markets the product in Europe, is downplaying the shot's link to the deaths. Medical Director Nicholas Kitchin told The Telegraph that German and Austrian officials have "looked pretty extensively" at the two deaths and haven't found evidence that the vaccine caused them.

Previously, the U.S. Centers for Disease Control and Prevention announced four deaths in young women who'd been vaccinated with Gardasil, but officials said that the deaths didn't appear to be caused by the shot. At the time, 5 million doses of Gardasil had been distributed in the U.S., but the number of patients who'd received shots was unknown.

- see the release from the EMEA
- read the Telegraph article
- here's more on the U.S. data in Entrepreneur

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.